From: Methotrexate and actinomycin D chemotherapy in a patient with porphyria: a case report
Type of porphyria | Enzyme inheritance | Inheritance | Clinical manifestation | Urine concentration | ||
---|---|---|---|---|---|---|
Skin | Neuropsychiatric | |||||
Plumboporphyria | Porphobilinogen synthase | AR, 9q34 | - | ++ | ALA COPRO-gen III | |
Acute intermittent porphyria | Hydroxymethylbilane synthase | AD, 11q23 | - | ++ | Abdominal pain, neuropathy, mental changes, and tachycardia | PBG σ-ALA |
Congenital erythropoietic | Uroporphyrinogen III synthase | AR, 10q26 | + | - | Skin lesion and hepatopathy in early childhood | UPG I COPRO-gen I |
Porphyria cutanea tarda | Uroporphyrinogen decarboxylase | AD, 1q34 | ++ | - | Dark urine, occurring after middle age | UPG |
Hereditary coproporphyria | Coproporphyrinogen oxidase | AD, 9 | + | + | Abdominal pain and peripheral, neuropathy | PBG>ALA COPRO-gen III |
Variegate porphyria | Protoporphyrinogen oxidase | 1q14 | + | + | PBG>ALA COPRO-gen III | |
Erythropoietic protoporphyria | Ferrochelatase | 18q21, 3 | + | - | Skin lesion and hepatopathy in early childhood | Not increased (PP in erythrocyte) |